Sugi Predict

Sugi Predict / Compounds / SCHEMBL716239

SCHEMBL716239

SCHEMBL716239

O=S(=O)(O)C(F)(C(F)(F)F)C(F)(F)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CA2 P00918 3/20 0.37
▸ CA1 P00915 2/20 0.37
▸ MMP1 P03956 2/20 0.37
▸ MMP2 P08253 2/20 0.37
▸ MMP9 P14780 2/20 0.37
▸ MMP8 P22894 2/20 0.37
▸ MMP13 P45452 2/20 0.37
▸ F2 P00734 2/20 0.33
▸ PRSS1 P07477 2/20 0.33
▸ PRSS2 P07478 2/20 0.33
▸ PRSS3 P35030 2/20 0.33
▸ TSHR P16473 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466477 0.92 CA2 (0.41) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL8535675 0.89 CA2 (0.43) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL8531817 0.89 CA2 (0.43) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL15648179 0.89 CA2 (0.43) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL296565 0.89 CA2 (0.43) ALDH1A1L3MBTL1CA2CA1MMP1
Ammonia Solution, Strong SCHEMBL6765844 0.87 CA2 (0.41) ALDH1A1L3MBTL1CA2CA1MMP1
Ammonia Solution, Strong SCHEMBL1579985 0.87 CA2 (0.41) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL716446 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL17979661 0.83 CA2 (0.39) ALDH1A1L3MBTL1CA2CA1MMP1
SCHEMBL2760983 0.83 ALDH1A1 (0.35) ALDH1A1L3MBTL1CA2CA1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623948-B2 Polycarbonate compositions having antistatic enhancers, method of preparing, and articles comprising the same SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-01-07 — — US claimed
US-20090326116-A1 POLYCARBONATE COMPOSITIONS HAVING ANTISTATIC ENHANCERS, METHOD OF PREPARING, AND ARTICLES COMPRISING THE SAME SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2009-12-31 — — US claimed
US-20200356001-A1 PHOTORESIST COMPOSITIONS AND METHODS OF FORMING RESIST PATTERNS WITH SUCH COMPOSITIONS ROHM AND HAAS ELECTRONIC MATERIALS LLC 2020-11-12 — — US disclosed
US-20200209743-A1 COMPOSITION FOR PREPARING THICK FILM PHOTOREST, THICK FILM PHOTORESIST, AND PROCESS OF PREPARING THE SAME ROHM & HAAS ELECT MAT (US) 2020-07-02 — — US disclosed
WO-2020055059-A1 ORGANIC LIGHT-EMITTING DIODE 주식회사 엘지화학 2020-03-19 — — WO disclosed
US-8623948-B2 Polycarbonate compositions having antistatic enhancers, method of preparing, and articles comprising the same SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-01-07 — — US disclosed
US-8357765-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-22 — — US disclosed
US-8288490-B2 Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-16 — — US disclosed
CN-102585051-A Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL CO 2012-07-18 — — CN disclosed
EP-2438486-A1 CHEMICALLY AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FujiFilm Electronic Materials USA, Inc. (US) 2012-04-11 — — EP disclosed
CN-102382130-A Process for producing catalyst component for addition polymerization SUMITOMO CHEMICAL CO 2012-03-21 — — CN disclosed
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 — — US disclosed
US-20120053311-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-01 — — US disclosed
EP-2321279-A1 DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 — — EP disclosed
WO-2010141444-A1 CHEMICALLY AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2010-12-09 — — WO disclosed
WO-2010015387-A1 DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-11 — — WO disclosed
WO-2010015340-A1 DAA-PYRIDINE AS PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR DIAGNOSTIC IMAGING AND PHARMACEUTICAL TREATMENT BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-11 — — WO disclosed
US-20090326116-A1 POLYCARBONATE COMPOSITIONS HAVING ANTISTATIC ENHANCERS, METHOD OF PREPARING, AND ARTICLES COMPRISING THE SAME SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2009-12-31 — — US disclosed
CN-1455663-A Novel aerosol formulation containing polar fluorinated molecule ASTRAZENECA AB (SE) 2003-11-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053306-A1 PROCESS FOR PRODUCING CATALYST COMPONENT FOR ADDITION POLYMERIZATION PPOX, SOD1, AP1M1 ALDH1A1 1442/4885L3MBTL1 4882/4885CA2 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.